相关实验视频
Updated: Jun 10, 2025

06:33
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
7.7K
遗传性转基因氨基粉症多神经病变
Taha Qarni1, Orly Moshe-Lilie2, Michelle C Kaku3
1Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania.
Seminars in neurology
|October 15, 2024
概括
遗传性转基因氨基粉症 (ATTRv) 的诊断和治疗在新的成像和疗法方面取得了重大进展. 目前正在进行的研究解决了诸如早期检测和管理复杂的表型等挑战,以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 医疗成像医学成像
背景情况:
- 遗传性转基因氨基粉症 (ATTRv) 是一种影响多个器官的渐进性疾病.
- 近年来,在ATTRv诊断,管理和患者监测方面取得了重大进展.
- 像活检这样的传统诊断方法越来越多地被先进的成像技术所补充.
研究的目的:
- 审查关于ATTRv多神经病及其管理的当前知识.
- 讨论加强早期诊断和ATTRv.监测的战略.
- 探索ATTRv研究和治疗的新兴趋势和未来方向.
主要方法:
- 审查ATTRv诊断的最新进展,包括像99米Tc-PYP扫描这样的成像技术.
- 分析当前和新兴的治疗策略,如反意义寡核酸和RNA干扰.
- 讨论ATTRv管理中的挑战,包括早期检测,混合表型和新出现的并发症.
主要成果:
- 由于新型治疗方法,ATTRv患者的生活质量和生存率显著改善.
- 99m Tc-PYP扫描正在成为用于疾病确认的活检的首选替代方案.
- 像CRISPR和粉样抗体这样的新兴疗法显示出未来的潜力.
结论:
- 尽管取得了进展,但在早期ATTRv诊断和管理方面仍然存在挑战.
- 未来的研究重点是预防性疗法,改进的生物标志物和针对耐药器官的向治疗.
- 新型成像和人工智能的整合有望增强ATTRv的诊断能力.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Enzyme-linked Receptors
77.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.5K
Translation
141.6K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.6K
Amyloid Fibrils
5.1K
5.1K
Chronic Kidney Disease II: Clinical Manifestations
2
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K

